Surgery Partners Inc
NASDAQ:SGRY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Surgery Partners Inc
NASDAQ:SGRY
|
US |
|
U
|
Unilever Indonesia Tbk PT
XBER:UTG
|
ID |
|
Main Street Capital Corp
NYSE:MAIN
|
US |
|
Peach Property Group AG
SIX:PEAN
|
CH |
|
Tesmec SpA
MIL:TES
|
IT |
|
Ather Energy Ltd
NSE:ATHERENERG
|
IN |
|
Pharol SGPS SA
OTC:PHRZF
|
PT |
|
Enterprise Financial Services Corp
NASDAQ:EFSC
|
US |
|
Aptitude Software Group PLC
LSE:APTD
|
UK |
|
A
|
Alphamin Resources Corp
JSE:APH
|
MU |
|
S
|
SSE PLC
OTC:SSEZY
|
UK |
|
Cadence Design Systems Inc
NASDAQ:CDNS
|
US |
|
Privia Health Group Inc
NASDAQ:PRVA
|
US |
|
S
|
Spigen Korea Co Ltd
KOSDAQ:192440
|
KR |
|
Chemung Financial Corp
NASDAQ:CHMG
|
US |
|
B
|
Bombardier Inc
OTC:BDRBF
|
CA |
|
Weatherford International PLC
NASDAQ:WFRD
|
US |
|
Agilysys Inc
NASDAQ:AGYS
|
US |
|
BRP Inc
TSX:DOO
|
CA |
|
Exlservice Holdings Inc
NASDAQ:EXLS
|
US |
|
B
|
Braxia Scientific Corp
CNSX:BRAX
|
CA |
|
AGCO Corp
NYSE:AGCO
|
US |
|
B
|
Banco Santander SA
VSE:SAN
|
ES |
|
CD Projekt SA
OTC:OTGLY
|
PL |
Wall St Price Targets
SGRY Price Targets Summary
Surgery Partners Inc
According to Wall Street analysts, the average 1-year price target for SGRY is 18.72 USD with a low forecast of 14.14 USD and a high forecast of 25.2 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SGRY's stock price target?
Price Target
18.72
USD
According to Wall Street analysts, the average 1-year price target for SGRY is 18.72 USD with a low forecast of 14.14 USD and a high forecast of 25.2 USD.
What is the Revenue forecast for Surgery Partners Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 4 years is 8%.
What is the Operating Income forecast for Surgery Partners Inc?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Operating Income has been 17%. The projected CAGR for the next 3 years is 0%.
